Reunion Neuroscience’s $103 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A financing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now